Introduction to cardiovascular disease, stress and adaptation

Stress and Cardiovascular Disease

Volumn 9781848824195, Issue , 2012, Pages 1-14

  Steptoe, Andrew ^a   Rosengren, Annika ^b   Hjemdahl, Paul ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adaptation; Ambulatory monitoring; Animal research; Cardiovascular disease; Naturalistic monitoring; Stress

Indexed keywords

EID: 84878574514     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-419-5_1     Document Type: Editorial

References (50)

1. Fink G (ed.) Encyclopedia of Stress, 4 vols. Oxford: Academic Press; 2007.
2. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953-962.
3. Petticrew MP, Lee K. The "Father of Stress" meets "Big Tobacco": Hans Selye and the tobacco industry. Am J Public Health. 2010;101(3):411-418.
4. McCarty R, Pacak K. Alarm phase and general adaptation syndrome. In: Fink G, ed. Encyclopedia of Stress, vol. 1. 2nd ed. Oxford: Elsevier; 2007:119-123.
5. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25-44.
6. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
7. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338: 171-179.
8. Lazarus RS. Psychological Stress and the Coping Process. New York: McGraw-Hill; 1966.
9. Brydon L, Walker C, Wawrzyniak AJ, et al. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun. 2009;23:810-816.
10. Chida Y, Hamer M. Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30 years of investigations. Psychol Bull. 2008;134:829-885.
11. Eisenberger NI, Taylor SE, Gable SL, et al. Neural pathways link social support to attenuated neuroendocrine stress responses. Neuroimage. 2007;35:1601-1612.
12. Grant N, Hamer M, Steptoe A. Social isolation and stress-related cardiovascular, lipid, and cortisol responses. Ann Behav Med. 2009;37:29-37.
13. Horsten M, Ericson M, Perski A, et al. Psychosocial factors and heart rate variability in healthy women. Psychosom Med. 1999;61:49-57.
14. Abbott DH, Keverne EB, Bercovitch FB, et al. Are subordinates always stressed? A comparative analysis of rank differences in cortisol levels among primates. Horm Behav. 2003;43:67-82.
15. Ely D, Caplea A, Dunphy G, et al. Physiological and neuroendocrine correlates of social position in normotensive and hypertensive rat colonies. Acta Physiol Scand Suppl. 1997; 640:92-95.
16. Singer MT. Engagement - involvement: a central phenomenon in psychophysiological research. Psychosom Med. 1974;36:1-17.
17. Kamarck TW, Lovallo WR. Cardiovascular reactivity to psychological challenge: conceptual and measurement considerations. Psychosom Med. 2003;65:9-21.
18. Hamer M, Gibson EL, Vuononvirta R, et al. Inflammatory and hemostatic responses to repeated mental stress: individual stability and habituation over time. Brain Behav Immun. 2006;20:456-459.
19. Bohlin G, Eliasson K, Hjemdahl P, et al. Pace variation and control of work pace as related to cardiovascular, neuroendocrine and subjective responses. Biol Psychol. 1986;23:247-263.
20. Kamarck TW, Manuck SB, Jennings JR. Social support reduces cardiovascular reactivity to psychological challenge: a laboratory model. Psychosom Med. 1990;52:42-58.
21. Steptoe A, Feldman PM, Kunz S, et al. Stress responsivity and socioeconomic status: a mechanism for increased cardiovascular disease risk? Eur Heart J. 2002;23:1757-1763.
22. Steptoe A, Poole L. Use of biological measures in behavioral medicine. In: Steptoe A, ed. Handbook of Behavioral Medicine. New York: Springer; 2010:619-632.
23. Steptoe A, Vögele C. The methodology of mental stress testing in cardiovascular research. Circulation. 1991;83:II14-II24.
24. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a metaanalytic study of 30 years of inquiry. Psychol Bull. 2004;130:601-630.
25. Kiecolt-Glaser JK, Loving TJ, Stowell JR, et al. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry. 2005;62:1377-1384.
26. Parati G, Trazzi S, Ravogli A, et al. Methodological problems in evaluation of cardiovascular effects of stress in humans. Hypertension. 1991;17(4 Suppl):III50-III55.
27. Chida Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension. 2010;55:1026-1032.
28. Landsbergis PA, Schnall PL, Pickering TG, et al. Life-course exposure to job strain and ambulatory blood pressure in men. Am J Epidemiol. 2003;157:998-1006.
29. Vrijkotte TG, van Doornen LJ, de Geus EJ. Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension. 2000;35:880-886.
30. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26:1290-1299.
31. Schwartz JE, Stone AA. Strategies for analyzing ecological momentary assessment data. Health Psychol. 1998;17:6-16.
32. Costa M, Cropley M, Griffith J, et al. Ambulatory blood pressure monitoring is associated with reduced physical activity during everyday life. Psychosom Med. 1999;61:806-811.
33. Elwood M. Critical Appraisal of Epidemiological Studies and Clinical Trials. 3rd ed. Oxford: Oxford University Press; 2007.
34. Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303:1159-1166.
35. Strike PC, Steptoe A. Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom Med. 2005;67:179-186.
36. Rissanen V, Romo M, Siltanen P. Premonitory symptoms and stress factors preceding sudden death from ischaemic heart disease. Acta Med Scand. 1978;204:389-396.
37. Greene WA, Goldstein S, Moss AJ. Psychosocial aspects of sudden death. A preliminary report. Arch Intern Med. 1972;129:725-731.
38. Pickering TG. Now we are sick: labeling and hypertension. J Clin Hypertens (Greenwich). 2006;8:57-60.
39. Hamer M, Batty GD, Stamatakis E, et al. Hypertension awareness and psychological distress. Hypertension. 2010;56:547-550.
40. Rostrup M, Kjeldsen SE, Eide IK. Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test. Am J Hypertens. 1990;3(12 Pt 1):912-917.
41. Rostrup M, Mundal HH, Westheim A, et al. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens. 1991;9:159-166.
42. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.
43. Ogilvie D, Craig P, Griffin S, et al. A translational framework for public health research. BMC Public Health. 2009;9:116.
44. Lewin B, Robertson IH, Cay EL, et al. Effects of self-help post-myocardial-infarction rehabilitation on psychological adjustment and use of health services. Lancet. 1992;339: 1036-1040.
45. Moore RK, Groves DG, Bridson JD, et al. A brief cognitive-behavioral intervention reduces hospital admissions in refractory angina patients. J Pain Symptom Manage. 2007;33:310-316.
46. Freedland KE, Carney RM, Lustman PJ. Trial design in behavioral medicine. In: Steptoe A, ed. Handbook of Behavioral Medicine. New York: Springer; 2010:925-939.
47. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008; 148:295-309.
48. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
49. Melander H, Ahlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003;326:1171-1175.
50. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.